✦ LIBER ✦

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

✍ Scribed by Lu, Genmin; DeGuzman, Francis R; Hollenbach, Stanley J; Karbarz, Mark J; Abe, Keith; Lee, Gail; Luan, Peng; Hutchaleelaha, Athiwat; Inagaki, Mayuko; Conley, Pamela B; Phillips, David R; Sinha, Uma

Book ID: 120039309
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 608 KB
Volume: 19
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm.3102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibrin-targeted direct factor Xa inhibit

Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide

✍ Hagemeyer, Christoph E.; Tomic, Ivo; Jaminet, Patrick; Weirich, Uta; Bassler, Ni 📂 Article 📅 2004 🏛 Schattauer 🌐 English ⚖ 128 KB

Measuring oral direct inhibitors of thro

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

✍ Baglin, T.; Hillarp, A.; Tripodi, A.; Elalamy, I.; Buller, H.; Ageno, W. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Reversal of New, Factor-specific Oral An

Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies

✍ Lee, Frank M.H.; Chan, Anthony K.C.; Lau, Keith K.; Chan, Howard H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 310 KB

C0125 In vitro effect of the direct Xa i

C0125 In vitro effect of the direct Xa inhibitor, apixaban, on global coagulation laboratory tests and coagulation factor assays: Comparison of 10 aPTT and 10 PT reagents, and two coagulometers. A “Groupe D’Etude sur l'Hémostase et la Thrombose” study

✍ Isabelle, Gouin-Thibault; Claire, Flaujac; Marie-Hélène, Horellou; Nicole, Lacar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Dose Selection for a Direct and Selectiv

Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design

✍ T. J. Povsic; M. G. Cohen; M. Y. Chan; S. L. Zelenkofske; W. A. Wargin; R. A. Ha 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 277 KB

Mechanism of Protein Kinase B Activation

Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer

✍ Ivana Galetic.; Mirjana Andjelkovic.; Roger Meier; Daniela Brodbeck; Jongsun Par 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 513 KB